STOCK TITAN

ProShares Ultra CRCL ETF (CRCA) Stock Price, News & Analysis

CRCA NYSE

Company Description

ProShares Ultra CRCL (CRCA) is an exchange-traded fund offered by ProShares, an ETF sponsor known for geared strategies, including leveraged and inverse ETF investing. The fund is part of a ProShares lineup that includes products tied to dividend growth, high income, interest-rate-hedged bonds, crypto exposure, and tactical ETF strategies.

As a ProShares ETF, ProShares Ultra CRCL is associated with fund-level mechanics and risks typical of the sponsor's geared products. ProShares materials describe its ETFs as generally non-diversified and note that certain funds may use derivatives such as swap agreements, futures contracts, and similar instruments. These instruments, along with leverage, imperfect benchmark correlation, and market price variance, can increase volatility and affect fund performance.

Recent ProShares fund communications also address ETF share actions such as reverse share splits. A reverse split changes the number of shares outstanding and the per-share trading price but does not, by itself, change the total value of a shareholder's investment. CRCA's public-company profile is therefore best understood as a fund reference record tied to ProShares' ETF platform rather than as an operating business with products, customers, or operating segments.

Stock Performance

$12.18
+6.94%
+0.79
Last updated: July 30, 2026 at 14:44
-
Performance 1 year

ProShares Ultra CRCL ETF (CRCA) last closed at $11.39.

See what a $1,000 investment in CRCA would be worth today

Latest News

ProShares Ultra CRCL ETF has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all CRCA news →

SEC Filings

No SEC filings available for CRCA.

Financial Highlights

Revenue (latest FY)
Net Income (latest FY)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in ProShares Ultra CRCL ETF (CRCA) currently stands at 1.4 million shares, up 17.4% from the previous reporting period, representing 21.6% of the shares outstanding. Since August 2025, short interest has increased by 173.6%.

Days to Cover History

Last 12 Months

Days to cover for ProShares Ultra CRCL ETF (CRCA) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.

Frequently Asked Questions

What is the current quoted price of ProShares Ultra CRCL ETF (CRCA)?

The current quoted price of ProShares Ultra CRCL ETF (CRCA) is $11.39 as of July 29, 2026.

What is ProShares Ultra CRCL (CRCA)?

ProShares Ultra CRCL (CRCA) is an exchange-traded fund offered by ProShares.

Who sponsors ProShares Ultra CRCL?

The fund is offered by ProShares, an ETF provider that has offered ETFs since 2006 and manages a broad lineup of exchange-traded funds.

What type of ETF strategy is associated with ProShares Ultra funds?

ProShares materials describe the firm as a leader in geared ETF investing, including leveraged and inverse strategies.

What risks are described for ProShares ETFs?

ProShares states that its ETFs are generally non-diversified and may involve derivatives, leverage, imperfect benchmark correlation, market price variance, and higher volatility.

What is a reverse share split for a ProShares ETF?

A reverse share split reduces the number of ETF shares outstanding and increases the per-share trading price proportionally. ProShares states that such a split does not change the total value of a shareholder's investment by itself.